Multidisciplinary management of meningiomas in the era of precision oncology.
A comprehensive framework now guides treatment of rare brain tumors using precision medicine tools, expanding options for an underserved population.
This Nature Reviews Clinical Oncology article provides a comprehensive multidisciplinary framework for meningioma management incorporating precision oncology tools including WHO 2021 molecular grading, targeted therapies, and advanced imaging biomarkers. It addresses an underserved CNS tumor population with limited systemic therapy options.
What the study was
- Study design
- Expert consensus narrative review
- Population
- Meningioma patients
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- Nature reviews. Clinical oncology
Why it surfaced
Nat Rev Clin Oncol review on precision oncology for meningiomas; high visibility publication, addresses emerging therapeutic vulnerability in underserved CNS tumor.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.